Tenaya Therapeutics WKN: A3CWF0 ISIN: US87990A1060 Kürzel: TNYA Forum: Aktien User: 00000

Tenaya Therapeutics (Nasdaq: TNYA) priced an underwritten public offering of 50,000,000 units at $1.20 per unit for gross proceeds of $60.0 million before discounts, commissions and expenses. Each unit consists of one share of common stock and a warrant to purchase one share at an exercise price of $1.50; warrants expire five years from issuance and are immediately exercisable. The company intends to use net proceeds to fund development of clinical and early-stage candidates, particularly TN-201 and TN-401, and for working capital. Closing is expected on or about December 15, 2025, subject to customary conditions.